The Best Molecular Biomarkers Available for Informing Immunotherapy of Cancer

David Spigel, MD

Video Categories: 2018 ASCO Insights, Biomarkers, and Video Library

Dr David Spigel talks about currently available and emerging biomarkers that predict the greatest sensitivity to immunotherapy, including his insight into PD-L1, MSI, and TMB.

July 29, 2015

The Status of the Standard of Care for Cancer Patients

Dr. Alex Adjei discusses how the standard of care for cancer patients has improved overt he last few years, but there is still a great need for new treatments designed to help a broader range of cancer patients.

January 20, 2016

Discussing the Results of BBI608 Combined with Another Therapeutic Agent

Dr Wainberg and Dr Gerson talk about the results of using investigational agent BBI608 combined with another drug that is used as a standard of care.